Table of Contents
Letter of Acknowledgement4
GSK CONSUMER HEALTH CARE SEGMENT13
Supply chain activities:14
Internal Factors Evaluation (IFE):19
External Factors Evaluation (EFE):20
THE INTERNAL-EXTERNAL (IE) MATRIX24
Current strategy of the company25
CPM (COMPETITIVE PROFILE MATRIX)26
INTERPRETATION OF CPM MATRIX:26
Acid Test Ratio:30
Net Profit Margin:32
Return On Equity:33
Total asset turnover:34
Earnings per share:35
Other Important Financial Data36
Letter of Acknowledgement
Institute of Business Management
Korangi Creek, Karachi-75190, Pakistan
UAN (9221)111-002-004, Fax: (9221) 509-0968
April 24, 2012
It is an honor for us to prepare the report on “GlaxoSmithKline” which was assigned to us by our teacher Sir Abdul Qadir Molvi. We would like to thank him for providing us information and guidance throughout our report in order to materialize our content for the report. It was a pleasure creating such a report, on a topic so relevant, informative and insightful. Thanking You.
Ahmed Saeed Khan
Anum Ali Junejo
This is a research on GlaxoSmithKline a pharmaceutical concern has been conducted to primarily understand two aspects. First is to comprehend the current strategy of the company and second is to suggest an apt strategy to the company after analyzing the conditions of the pharmaceutical industry and the political, social and legal environment at large. The report would further elaborate on the main strengths and weaknesses of the company and take into consideration the threats and opportunities for the company to consider. The report will be ended by some key financial analysis and the conclusion stating and reinforcing the strategy suggested to understand the depth of the analysis in much more detail.
The Company, GSK is the research based pharmaceutical company and its operations are spread globally. Their mission is to develop innovative medicines and products that help millions of people around the world. They are one of the few pharmaceutical companies researching both medicines and vaccines for the World Health Organization’s three priority diseases – HIV/AIDS, tuberculosis and malaria, and are very proud to have developed some of the leading global medicines in these fields. They produce medicines that treat six major disease areas: asthma, virus control, infections, mental health, diabetes and digestive conditions. In addition, they are a leader in the important area of vaccines and are developing new treatments for cancer. Bring a leader brings responsibility. This means that they care about the impact that they have on the people and places touched by their mission to improve health around the world.
GlaxoSmithKline’s vision has translated into a decade of excellence and achievement: “the opportunity to make a difference to the lives of billions of people” Every member of the GSK family strives to contribute his/her time, talents, and ideas to make a real and meaningful contribution towards improving the quality of human life. GSK is driven by performance, but they strongly believe that there is no achievement without integrity. They contribute to the health and well being of people with enthusiasm and vigor.
GlaxoSmithKline has a challenging and inspiring mission:
“to advance the quality of human lives by enabling people to DO MORE , FEEL BETTER ,...